Variation Of Normal Protein Could Be Key To Resistance To Common Cancer Drug

Researchers have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.

Read the whole article on Science Daily

More from Science Daily